메뉴 건너뛰기




Volumn 30, Issue SUPPL. 1, 2007, Pages 24-28

Streptococcus pneumoniae bacteraemia in children

Author keywords

Bacteraemia; Children; Conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; C REACTIVE PROTEIN; CEFOTAXIME; CEFTRIAXONE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE; PROCALCITONIN;

EID: 34848836078     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.06.018     Document Type: Article
Times cited : (17)

References (27)
  • 1
    • 34848826544 scopus 로고    scopus 로고
    • Global Programme for Vaccines and Immunization. Report of the meeting of the Scientific Group of Experts (SAGE) of the Children's Vaccine Initiative and the Global Programme for Vaccines and Immunization. Geneva, Switzerland: World Health Organization, 1996.
  • 2
    • 0027925716 scopus 로고
    • Immunization of adults
    • Gardner P., and Schaffner W. Immunization of adults. N Engl J Med 328 (1993) 1252-1258
    • (1993) N Engl J Med , vol.328 , pp. 1252-1258
    • Gardner, P.1    Schaffner, W.2
  • 3
    • 0019959136 scopus 로고
    • Epidemiologic studies of Streptococcus pneumoniae in infants: The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life
    • Gray B.M., Turner M.E., and Dillon Jr. H.C. Epidemiologic studies of Streptococcus pneumoniae in infants: The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol 116 (1982) 692-703
    • (1982) Am J Epidemiol , vol.116 , pp. 692-703
    • Gray, B.M.1    Turner, M.E.2    Dillon Jr., H.C.3
  • 4
    • 0026632872 scopus 로고
    • Nasopharyngeal colonization during the first year of life
    • Aniansson G., Alm B., Anderson B., et al. Nasopharyngeal colonization during the first year of life. J Infect Dis 165 (1992) S38-S42
    • (1992) J Infect Dis , vol.165
    • Aniansson, G.1    Alm, B.2    Anderson, B.3
  • 5
    • 0016741798 scopus 로고
    • Spread of Streptococcus pneumoniae in families: Carriage rates and distribution of types
    • Hendley J.O., Sande M.A., Stewart P.M., and Gwaltney J.M.J. Spread of Streptococcus pneumoniae in families: Carriage rates and distribution of types. J Infect Dis 132 (1975) 55-61
    • (1975) J Infect Dis , vol.132 , pp. 55-61
    • Hendley, J.O.1    Sande, M.A.2    Stewart, P.M.3    Gwaltney, J.M.J.4
  • 6
    • 0035941954 scopus 로고    scopus 로고
    • Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children
    • Hausdorff W.P., Siber G., and Paradiso P.R. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 357 (2001) 950-952
    • (2001) Lancet , vol.357 , pp. 950-952
    • Hausdorff, W.P.1    Siber, G.2    Paradiso, P.R.3
  • 7
    • 0026497498 scopus 로고
    • High incidence rates of invasive pneumococcal disease in the White Mountain Apache population
    • Cortese M.M., Wolff M., Almeido-Hill J., et al. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med 152 (1992) 2277-2282
    • (1992) Arch Intern Med , vol.152 , pp. 2277-2282
    • Cortese, M.M.1    Wolff, M.2    Almeido-Hill, J.3
  • 8
    • 17444450054 scopus 로고    scopus 로고
    • Three-year multicenter surveillance of systemic pneumococcal infections in children
    • Kaplan S.L., Mason E.O., Barson W.J., et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 102 (1998) 538-545
    • (1998) Pediatrics , vol.102 , pp. 538-545
    • Kaplan, S.L.1    Mason, E.O.2    Barson, W.J.3
  • 9
    • 0033842836 scopus 로고    scopus 로고
    • Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome
    • Alpern E.R., Alessandrini E.A., Bell L.M., Shaw K.N., and McGowan K.L. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 106 (2000) 505-511
    • (2000) Pediatrics , vol.106 , pp. 505-511
    • Alpern, E.R.1    Alessandrini, E.A.2    Bell, L.M.3    Shaw, K.N.4    McGowan, K.L.5
  • 10
    • 0035102439 scopus 로고    scopus 로고
    • Procalcitonin, IL-6, 1L-8, IL-1 receptor antagonist and C-reactive protein dosage as identificators of severe bacterial infections in children with fever without localising signs
    • Galetto Lacour A., Gervaix A., Zamora S., et al. Procalcitonin, IL-6, 1L-8, IL-1 receptor antagonist and C-reactive protein dosage as identificators of severe bacterial infections in children with fever without localising signs. Eur J Pediatr 160 (2001) 95-100
    • (2001) Eur J Pediatr , vol.160 , pp. 95-100
    • Galetto Lacour, A.1    Gervaix, A.2    Zamora, S.3
  • 11
    • 33645456949 scopus 로고    scopus 로고
    • Fever without source in children 0-36 months of age
    • Ishimine P. Fever without source in children 0-36 months of age. Pediatr Clin N Am 53 (2006) 167-194
    • (2006) Pediatr Clin N Am , vol.53 , pp. 167-194
    • Ishimine, P.1
  • 12
    • 84886608711 scopus 로고
    • Bacteremia in febrile children under 2 years of age: results of culture of blood of 600 consecutive febrile children seen in a "walk-in" clinic
    • Teele D.W., Pelton S.I., Grant M.J., et al. Bacteremia in febrile children under 2 years of age: results of culture of blood of 600 consecutive febrile children seen in a "walk-in" clinic. J Pediatr 87 (1975) 227-230
    • (1975) J Pediatr , vol.87 , pp. 227-230
    • Teele, D.W.1    Pelton, S.I.2    Grant, M.J.3
  • 13
    • 0022614841 scopus 로고
    • Risk factors for development of bacterial meningitis among children with occult bacteremia
    • Shapiro E.D., Aaron N.H., Wald E.R., and Chiponis D. Risk factors for development of bacterial meningitis among children with occult bacteremia. J Pediatr 109 (1986) 15-19
    • (1986) J Pediatr , vol.109 , pp. 15-19
    • Shapiro, E.D.1    Aaron, N.H.2    Wald, E.R.3    Chiponis, D.4
  • 14
    • 0027173402 scopus 로고
    • Practice guideline for the management of infants and children 0 to 36 months of age with fever without source
    • Baraff L.J., Bass J.W., Fleischer G.R., et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics 92 (1993) 1-12
    • (1993) Pediatrics , vol.92 , pp. 1-12
    • Baraff, L.J.1    Bass, J.W.2    Fleischer, G.R.3
  • 15
    • 0033013205 scopus 로고    scopus 로고
    • Evaluation of the infant with fever without source: an evidence based approach
    • Slater M., and Krug S.E. Evaluation of the infant with fever without source: an evidence based approach. Emerg Med Clin North Am 17 (1999) 97-126
    • (1999) Emerg Med Clin North Am , vol.17 , pp. 97-126
    • Slater, M.1    Krug, S.E.2
  • 16
    • 0032787367 scopus 로고    scopus 로고
    • Occult bacteremia in young febrile children
    • Kuppermann N. Occult bacteremia in young febrile children. Pediatr Clin North Am 46 (1999) 1073-1107
    • (1999) Pediatr Clin North Am , vol.46 , pp. 1073-1107
    • Kuppermann, N.1
  • 17
    • 0242300672 scopus 로고    scopus 로고
    • Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center
    • Galetto Lacour A., Zamora S.A., and Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 112 (2003) 1054-1060
    • (2003) Pediatrics , vol.112 , pp. 1054-1060
    • Galetto Lacour, A.1    Zamora, S.A.2    Gervaix, A.3
  • 18
    • 0142025400 scopus 로고    scopus 로고
    • Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker
    • Fernandez Lopez A., Luaces Cubells C., Garcia Garcia J.J., and Fernandez Pou J. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 22 (2003) 895-903
    • (2003) Pediatr Infect Dis J , vol.22 , pp. 895-903
    • Fernandez Lopez, A.1    Luaces Cubells, C.2    Garcia Garcia, J.J.3    Fernandez Pou, J.4
  • 19
    • 4644371441 scopus 로고    scopus 로고
    • Procalcitonin as a early marker of infection in neonates and children
    • Van Rossum A.M., Wulkan R.W., and Oudesluys-Murphy A.M. Procalcitonin as a early marker of infection in neonates and children. Lancet Infect Dis 4 (2004) 620-630
    • (2004) Lancet Infect Dis , vol.4 , pp. 620-630
    • Van Rossum, A.M.1    Wulkan, R.W.2    Oudesluys-Murphy, A.M.3
  • 20
    • 29244481998 scopus 로고    scopus 로고
    • Trends in antibiotic resistance of respiratory tract pathogens in children in Geneva, Switzerland
    • Jaecklin T., Rohner P., Jacomo V., Schmidheiny K., and Gervaix A. Trends in antibiotic resistance of respiratory tract pathogens in children in Geneva, Switzerland. Eur J Pediatr 165 (2006) 3-8
    • (2006) Eur J Pediatr , vol.165 , pp. 3-8
    • Jaecklin, T.1    Rohner, P.2    Jacomo, V.3    Schmidheiny, K.4    Gervaix, A.5
  • 21
    • 0033959859 scopus 로고    scopus 로고
    • Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, Part I
    • Hausdorff W.P., Bryant J., Paradiso P.R., and Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, Part I. Clin Infect Dis 30 (2000) 100-121
    • (2000) Clin Infect Dis , vol.30 , pp. 100-121
    • Hausdorff, W.P.1    Bryant, J.2    Paradiso, P.R.3    Siber, G.R.4
  • 22
    • 0242684416 scopus 로고    scopus 로고
    • Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
    • Withney C.G., Farley M.M., Hadler J., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
    • (2003) N Engl J Med , vol.348 , pp. 1737-1746
    • Withney, C.G.1    Farley, M.M.2    Hadler, J.3
  • 23
    • 3042681310 scopus 로고    scopus 로고
    • Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser permanente
    • Black S., Shinefield H., Baxter R., et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser permanente. Pediatr Infect Dis J 23 (2004) 485-489
    • (2004) Pediatr Infect Dis J , vol.23 , pp. 485-489
    • Black, S.1    Shinefield, H.2    Baxter, R.3
  • 24
    • 3042739901 scopus 로고    scopus 로고
    • Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine
    • Stoll M.L., and Rubin L.G. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine. Arch Pediatr Adolesc Med 158 (2004) 671-675
    • (2004) Arch Pediatr Adolesc Med , vol.158 , pp. 671-675
    • Stoll, M.L.1    Rubin, L.G.2
  • 25
    • 27244440305 scopus 로고    scopus 로고
    • Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
    • Lexau C.A., Lynfield R., Danila R., et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294 (2005) 2043-2051
    • (2005) JAMA , vol.294 , pp. 2043-2051
    • Lexau, C.A.1    Lynfield, R.2    Danila, R.3
  • 26
    • 24944542396 scopus 로고    scopus 로고
    • CDC. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR 2005:54;893-7.
  • 27
    • 33645505114 scopus 로고    scopus 로고
    • Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
    • Kyaw M.H., Lynfield R., Schaffner W., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 (2006) 1455-1463
    • (2006) N Engl J Med , vol.354 , pp. 1455-1463
    • Kyaw, M.H.1    Lynfield, R.2    Schaffner, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.